(Q35490468)

8 August 2017

1 reference

title

Barriers to use of pharmacotherapy for addiction disorders and how to overcome them (English)

1 reference

8 August 2017

0 references

Elizabeth M Oliva

1

1 reference

8 August 2017

Natalya C Maisel

series ordinal

2

1 reference

8 August 2017

Adam J Gordon

series ordinal

3

1 reference

8 August 2017

Alex H S Harris

series ordinal

4

1 reference

8 August 2017

language of work or name

English

0 references

publication date

1 October 2011

1 reference

Current Psychiatry Reports

8 August 2017

1 reference

8 August 2017

13

1 reference

8 August 2017

374-381

1 reference

8 August 2017

5

1 reference

https://scigraph.springernature.com/pub.10.1007/s11920-011-0222-2

8 August 2017

0 references

cites work

Psychiatrist characteristics that influence use of buprenorphine medication-assisted treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4403628

The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of substance use and related disorders. Part 2: Opioid dependence

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4403628

Buprenorphine: new treatment of opioid addiction in primary care.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4403628

Community-based addiction treatment staff attitudes about the usefulness of evidence-based addiction treatment and CBO organizational linkages to research institutions

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4403628

Counselor attitudes toward the use of naltrexone in substance abuse treatment: a multi-level modeling approach

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4403628

Using medication-assisted treatment for substance use disorders: evidence of barriers and facilitators of implementation

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4403628

Adoption and implementation of medications in addiction treatment programs

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4403628

Integrating addiction medicine into graduate medical education in primary care: the time has come

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4403628

Adoption of medications in substance abuse treatment: priorities and strategies of single state authorities

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4403628

Facilitating factors and barriers to the use of medications in publicly funded addiction treatment organizations

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4403628

Acamprosate for alcohol dependence

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4403628

Methadone maintenance and the cost and utilization of health care among individuals dependent on opioids in a commercial health plan

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4403628

Efficacy and tolerability of naltrexone in the management of alcohol dependence

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4403628

The Physician Clinical Support System-Buprenorphine (PCSS-B): a novel project to expand/improve buprenorphine treatment

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4403628

Understanding attitudes towards use of medication in substance abuse treatment: A multilevel approach

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4403628

Partnerships and pathways of dissemination: the National Institute on Drug Abuse-Substance Abuse and Mental Health Services Administration Blending Initiative in the Clinical Trials Network

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4403628

The pharmacological treatment of opioid addiction--a clinical perspective

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4403628

Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4403628

Buprenorphine adoption in the National Drug Abuse Treatment Clinical Trials Network.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4403628

Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4403628

Counselor attitudes toward pharmacotherapies for alcohol dependence.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4403628

Integrating buprenorphine treatment into office-based practice: a qualitative study

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4403628

Outcomes of DATA 2000 certification trainings for the provision of buprenorphine treatment in the Veterans Health Administration

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4403628

Factors associated with the prescribing of buprenorphine or methadone for treatment of opiate dependence

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4403628

What explains the diffusion of treatments for mental illness?

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4403628

Alcohol and opioid dependence medications: prescription trends, overall and by physician specialty

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4403628

Factors affecting willingness to provide buprenorphine treatment

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4403628

Office-based management of opioid dependence with buprenorphine: clinical practices and barriers

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4403628

State policy influence on the early diffusion of buprenorphine in community treatment programs

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4403628

Narrative review: buprenorphine for opioid-dependent patients in office practice

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4403628

Role of state policies in the adoption of naltrexone for substance abuse treatment

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4403628

Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4403628

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Substance Use and Related Disorders, Part 1: Alcoholism

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4403628

Barriers to obtaining waivers to prescribe buprenorphine for opioid addiction treatment among HIV physicians

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4403628

Availability of addiction medications in private health plans

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4403628

Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4403628

The adoption of medications in substance abuse treatment: associations with organizational characteristics and technology clusters

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4403628

Attending physicians' and residents' attitudes and beliefs about prescribing buprenorphine at an urban teaching hospital.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4403628

Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4403628

Neurobiology of addiction: treatment and public policy ramifications

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4403628

Acamprosate for the treatment of alcohol dependence

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4403628

Challenges in increasing access to buprenorphine treatment for opiate addiction

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4403628

Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4403628

Barriers to the use of medications to treat alcoholism.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4403628

Naltrexone, a relapse prevention maintenance treatment of alcohol dependence: a meta-analysis of randomized controlled trials

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4403628

The cost-effectiveness of buprenorphine maintenance therapy for opiate addiction in the United States

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4403628

Efficacy of naltrexone and acamprosate for alcoholism treatment: a meta-analysis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4403628

The efficacy of acamprosate and naltrexone in the treatment of alcohol dependence: a relative benefits analysis of randomized controlled trials

12 July 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0222-2

Efficacy of Naltrexone and Acamprosate for Alcoholism Treatment: A Meta-Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0222-2

Acamprosate supports abstinence, naltrexone prevents excessive drinking: evidence from a meta-analysis with unreported outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0222-2

Buprenorphine versus methadone maintenance therapy: a randomized double-blind trial with 405 opioid-dependent patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0222-2

Comparison of costs and utilization among buprenorphine and methadone patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0222-2

Office-based treatment for opioid dependence: reaching new patient populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0222-2

Opioid use disorder in the United States: insurance status and treatment access

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0222-2

Policy implications of integrating buprenorphine/naloxone treatment and HIV care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0222-2

Barriers to opioid substitution treatment access, entry and retention: a survey of opioid users, patients in treatment, and treating and non-treating physicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0222-2

Does following research-derived practice guidelines improve opiate-dependent patients' outcomes under everyday practice conditions? Results of the Multisite Opiate Substitution Treatment study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0222-2

Substance abuse treatment organizations as mediators of social policy: slowing the adoption of a congressionally approved medication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0222-2

Challenges to medications development in treating alcohol dependence: an international perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0222-2

Knowledge and attitudes about pharmacotherapy for alcoholism: a survey of counselors and administrators in community-based addiction treatment centres.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0222-2

Barriers and facilitators to primary care or human immunodeficiency virus clinics providing methadone or buprenorphine for the management of opioid dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0222-2

Facilitators and barriers in implementing buprenorphine in the Veterans Health Administration

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4403628

Pharmacotherapy of alcohol use disorders in the Veterans Health Administration

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4403628

Research to practice: adoption of naltrexone in alcoholism treatment

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4403628

Opioid antagonists for alcohol dependence

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4403628

10.1007/S11920-011-0222-2

15 November 2018

Identifiers

DOI

1 reference

8 August 2017

1 reference

8 August 2017

1 reference